Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Evaluate the activity of Trastuzumab, Lapatinib, and a combination of both agents with
chemotherapy in the preoperative (neoadjuvant) treatment of early breast cancer.